drugset / Trial / NCT01896557

Ranitidin Versus Omeprazole in Patients Taking Clopidogrel

NCT01896557

RandomizedParallel-groupQuadruple-blindTreatment

Summary

Previous reports have shown a possible drug interaction between clopidogrel and proton pump inhibitors (PPI´s), which could result in increased number of adverse cardiovascular events among patients on dual antiplatelet therapy(DAPT). Because of this, ranitidin has been proposed as an alternative drug to PPI´s for prophylaxis of gastrointestinal bleeding in patients who need DAPT. The study´s aim is to test the hypothesis that ranitidin doesn´t have any influence on clopidogrel pharmacodynamic.

Timeline

Start
2011-10
Primary completion
2013-06
Completion
2013-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Clopidogrel Small molecule 75 mg
Subject Omeprazole Other / unclassified 20 mg Oral
Subject Ranitidine Unknown 150 mg